Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

FDA Approves First Treatment for Neurologic Symptoms of Type 3 Gaucher Disease

(MedPage Today) -- The FDA approved venglustat (Infilbray) tablets as the first treatment for neurologic symptoms of type 3 Gaucher disease in adults and children weighing at least 15 kg, the agency announced Wednesday. Gaucher disease is a rare...

FDA Approves First Treatment for Neurologic Symptoms of Type 3 Gaucher Disease

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Thursday 19 November →